Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2021 Jan-Mar;35(1):55–61. doi: 10.1097/WAD.0000000000000414

Table 1.

Diagnostic Tests “Ever” Used Clinically by Experts for Diagnosing Dementia with Lewy Bodies

Test Number (%) of Investigators Reporting Ever
Using the Test for DLB Diagnosis (n=22)
Neuropsychological testing 22 (100%)
Magnetic resonance imaging 20 (90.9%)
Dopamine transporter imaging 19 (86.4%)
Cerebrospinal fluid testing 15 (68.2%)
SPECT/PET perfusion/metabolism 14 (63.6%)
Polysomnography 13 (59.1%)
Genetic testing 7 (31.8%)
MIBG myocardial scintigraphy 3 (13.6%)
Quantitative EEG 2 (9.1%)

DLB: Dementia with Lewy bodies, SPECT: single-photon emission computed tomography, PET: positron emission tomography, MIBG: metaiodobenzylguanidine, EEG: electroencephalography